Position in ELAN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$533,758
+$17,546 QoQ
Shares Held
22,305
-2.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $17,208,250 across 29 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,687 | $2,779,297 | |
| 2 | ALKS |
Alkermes plc.
|
77,769 | $2,749,911 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
17,687 | $2,330,085 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
158,462 | $1,508,558 | |
| 5 | ZTS |
Zoetis Inc.
|
6,653 | $786,451 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
22,305 | $533,758 | |
| 7 | HLN |
Haleon plc
|
50,589 | $506,395 | |
| 8 | VTRS |
Viatris Inc
|
29,453 | $397,910 |
All Filings in ELAN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $533,758 | 22,305 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $516,212 | 22,811 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $546,962 | 27,158 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $361,940 | 25,346 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $386,179 | 36,779 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $383,390 | 31,659 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $461,647 | 31,426 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $362,164 | 25,098 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $602,555 | 37,012 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $608,367 | 40,830 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $577,960 | 51,420 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $670,428 | 66,643 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $567,938 | 60,419 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $426,649 | 34,914 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $403,461 | 32,511 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $721,795 | 36,770 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $885,338 | 33,934 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $997,131 | 35,135 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $977,906 | 30,665 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,069,978 | 30,844 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $881,939 | 29,947 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,091,944 | 35,603 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $745,451 | 26,690 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $793,113 | 36,975 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $731,660 | 32,678 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||